NEW EVENT! Cutting-edge Trends for Life Sciences at PACK EXPO Southeast
Discover all the latest packaging solutions for life sciences products at the all-new PACK EXPO Southeast in Atlanta, GA, March 10-12, 2025

Filling operations earn Facility of the Year Award

Boehringer Ingelheim sets new benchmark in biopharmaceutical production with filling and isolator equipment.

With the Bosch filling line, Boehringer Ingelheim can fill and close up to 400 containers/min, ranging from vials to single and double-chamber cartridges. Here, workers check the disposable tubes of the filling system.
With the Bosch filling line, Boehringer Ingelheim can fill and close up to 400 containers/min, ranging from vials to single and double-chamber cartridges. Here, workers check the disposable tubes of the filling system.

Microbes follow people everywhere—even into the highest-grade cleanrooms. Isolators can provide a remedy by separating people, machines, and pharmaceuticals to ensure the highest purity standards for the aseptic manufacture of biopharmaceuticals.

Pharmaceutical manufacturer Boehringer Ingelheim’s new facility in Biberach an der Riss, Germany, fulfils those requirements, winning the 2014 Facility of the Year Award (FOYA) from ISPE, the International Society for Pharmaceutical Engineering.

Equipped with filling and isolator technology from Bosch Packaging Technology, the facility was recognized in the equipment innovation category for the successful implementation of a flexible and transparent production facility for biopharmaceuticals. The plant uses aseptic manufacturing, providing flexible and transparent production of biopharmaceutical products in all important dosage forms.

Boehringer Ingelheim is among the world’s top 20 pharmaceutical companies, focusing on research, development, production, and marketing of high-quality therapies for use in human and animal medicine. In Biberach, Boehringer Ingelheim operates Europe’s largest facility for the development and manufacturing of pharmaceuticals with biotechnologically produced active ingredients, both for its own business and for contract manufacturing.

Aseptic production requirements

To increase its flexibility and capacity at this site, the company decided to expand and modernize the production of biopharmaceuticals. After two years of concept development and design studies, the company initiated an ambitious project involving the construction of two ultramodern filling lines with a joint connection to two freeze dryers in an existing production building.

“Our goal was to create a flexible production area for the manufacturing of all important biopharmaceutical dosage forms. It was supposed to meet today´s and future requirements for aseptic processing while allowing transparent and flexible production,” explains Dr Friedrich Haefele, Vice President BP Fill & Finish Germany at Boehringer Ingelheim.

INTRODUCING! The Latest Trends for Life Sciences at PACK EXPO Southeast
The exciting new PACK EXPO Southeast 2025 unites all vertical markets in one dynamic hub, generating more innovative answers to packaging challenges for life sciences products. Don’t miss this extraordinary opportunity for your business!
REGISTER FOR $30!
INTRODUCING! The Latest Trends for Life Sciences at PACK EXPO Southeast